Ahn J.Y., Lee H.J., C C.H. and Ha T.Y. (2011) High fat diet induced downregula-tion of microRNA-467b increased lipoprotein lipase in hepatic steatosis. Biochem-ical and Biophysical Research Communications 414:664-669.
Akiyama T.E., Lambert G., Nicol C.J., Matsusue K., Peters J.M., Brewer H.B., Jr B.B., and Gonzalez F.J. (2013) Preoxisome proliferator-activated receptor #westeur032#/δ regulates very low density lipoprotein production and catabolism in mice on a western diet. Journal of Biological Chemistry 279:20874-20881.
Alexander C.A, Hamilton R.L. and Havel R.J. (1976) Subcellular localization of B apoprotein of plasma lipoproteins in rat liver. The Journal of Cell Biology 69:241-263.
Arner P. (1995) Differences in lipolysis between human subcutaneous and omental adipose tissues. Annals of Internal Medicine 27:435-438.
B#westeur037#ckhed F., Ding H., Wang T., Hopper L.V., Koh G.Y., Nagy A., Semenkovich C.F. and Gordon J.I. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 101:15718-15723.
Bao Y., Lu Z., Zhou M., Li H., Wang Y., Gao M., Wei M. and Jia W. (2010) Serum levels of adipocyte fatty acid-binding protein are associated with the severity of coronary artery disease in Chinese women. PLoS One 6:19115-19121.
Begriche K., Igoudjil A., Pessayre D. and Feomenty B. (2006) Mitochondrial dys-function in NASH: causes, consequences and possible means to prevent it. Mito-chondrion 6:1-28.
Behrens I., Pena A.I., Alonso M.J. and Kissel T. (2002) Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharmaceutical Research 19:1185-1193.
Ben A.C. (2011) Chitin and Chitosan: Marine Biopolymers with unique properties and versatile application. Global Journal of Biotechnology &; Biochemistry 6: 149-153.
Berger J.J. and Barnard R.J. (1999) Effect of diet on fat cell size and hormone sen-sitive lipase activity. Journal of Applied Physiology 87:227-232.
Birkenmeier E.H., Gwynn S., Howard J., Jerry J.I., Gordon W.H., Landschulz and McKnight (1989) Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes &; Development 3:1146-1156.
Boord J.B., Maeda K., Makowski L., Babaev V.R., Fazio S., Linton M.F and Ho-tamisligil G.S. (2002) Adipocyte fatty acid binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology 22:1686-1691.
Bor#westeur042#n J., Taskien M.R. and Adiels M. (2012) Kinetic studies to investigate lipopro-tein metabolism. Journal of Internal Medicine 271:166-173.
Brea A. and Puzo J. (2013) Non-alcoholic fatty liver disease and cardiovascular risk. International Journal of Cardiology 167:1109-1117.
Brown M.S. and Goldstein J.L. (1997) The SREBP pathway: regulation of choles-terol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331-340.
Bruun J.M., Lihn A.S., Verdich C., Pedersen S.B., Toubro S., Astrup A. and Richelsen B. (2003) Regulation of adiponecin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. American Journal of Physiology. Endocrinology and metabolism 285:527-533.
Cabre A., Lazaro I., Cofan M., Jarauta E., Plana N., Garcia-Otin A.L., Ascaso J.F., Ferr#westeur042# R., Civeira F., Ros E. and Masana L. (2009) FABP4 plasma levels are increased in familial combined hyperlipidemia. Journal of Lipid Research 51:1173-1178.
Cabre A., Lazaro I., Girona J., Manzanares J.M., Marimo´n F., Plana N., Heras M. and Masana L. (2007) Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis 195:150-158.
Cabre A., Lazaro I., Girona J., Manzanares J.M., Marimo´n F., Plana N., Heras M. and Masana L. (2008) Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria. Clinical Chemis-try 54:181-187.
Cabre A., Lazaro I., Girona J., Manzanares J.M., Marimo´n F., Plana N., Heras M. and Masana L. (2008) Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. Journal of Lipid Research 49:1746-51.
Cabr#westeur042# A., L#westeur034#zaro I., Girona J., Manzanares J.M., Marim#westeur052#n F., Plana N., Heras M. and Masana L. (2007) Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Journal of Ath-Erosclerosis Research 195:150-158.
Carling D. (2004) The AMPK-activated protein kinase cascade unifying system for energy control. Trends in Biochemical Sciences 29:18-24.
Carlson S.E. and Goldfarb S. (1977) A sensitive enzymatic method for determina-tion of free and esterified tissue cholesterol. Clinica Chimica Acta; International Journal of Clinical Chemistry 79:575-582.
Carmen G.Y. and Victor S.M. (2006) Signaling mechanisms regulating lipolysis. Cell signal 18:401-408.
Caro J.F., Dohm L.G., Pories W.J. and Sinha M.K. (1989) Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. Diabetes Metabolism Reviews 5:665-689.
Carruthers M., Trinick T.R., Jankowaka E. and Traish A.M. (2008) Are the ad-verse effects of glitazones linked to induced testosterone deficiency? Cardiovascu-lar Diabetology 7:1475-1479.
Chang X.X., Yan H.M., Fei J., Jiang M.H., Zhu H.G., Lu D.R. and Gao X. (2010) Berberine reduces methylation of the MTTP promoter and alleviates fatty liver in-duced by a high-fat diet in rats. Journal of Lipid Research 51:2504-2515.
Chen Y.D., Risser T.R., Cully M. and Reaven G.M. (1979) Is the hypertriglycer-idemia associated with insulin deficiency caused by decreased lipoprotein lipase activity? Diabetes 28:893-898.
Chiang M.T., Yao H.T. and Chen, H.C. (2000) Effect of dietary chitosans with dif-ferent viscosity on plasma lipids and lipid peroxidation in rats fed on a diet enriched with cholesterol. Bioscience Biotechnology and Biochemistry 64:965-971.
Choi H.G., Kim J.K., Kwak D.H., Cho J.R., Kim Y.J., Kim B.J., Jung K.Y., Choi B.K., Shin M.K. and Choo Y.K. (2002) Effect of high molecular weight wa-ter-soluble chitosan on ib vitro fertilization and ovulation in mice fed a high-fat diet. Archives of Pharmacal Reseach 25:178-183.
Christy R.J., Kaestner K.H., Geiman D.E., and Lane M.D. (1991) CCAAT/enhancer binding protein gene promoter: Binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proceedings of the National Academy of Sciences 88:2593-2597.
Chung Y.C., Wang H.L., Chen Y.M. and Li S.L. (2003) Effect of abiotic factors on the antibacterial activity of chitosan against waterborne pathogens. Bioresource Technology 88:179-184.
Coe N.R. and Bernlohr D.A. (1998) Physiological properties and functions of intra-cellular fatty acid-binding proteins. Biochimica et Biophysica Acta 1391:287-306.
Coll B., Cabre A., Alonso-Villaverde C., Lazaro I., Aragone´s G., Parra S., Gi-rona J. and Masana L. (2008) The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected pa-tients. Atherosclerosis 199:147-153.
Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohannesian J.P., Marco C.C., McKee L.J., Bauer T.L. and Caro J.F. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New England Journal of Medicine 334:292-295.
Cornelius P., MacDougald O. and Lane M. D. (1994) Regulation of adipocyte de-velopment. Annual Review of Nutrition 14, 99-129.
Cornelli U., Belcaro G., Cesarone M.R. and Cornelli M. (2008) Use of polyglu-cosamine and physical activity to reduce body weight and dyslipidemia in moder-ately overweight subjects. Minerva Cardioangiologica 56:71-78.
Corton J.M., Gillespie J.G., Hawley S.A. and Hardie D.G. (1995) 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? European Journal of Biochemistry 229:558-565.
Cruz W.S., Kwon G., Marshall C.A., McDanie M.L. and Semenkovich C.F. (2001) Glucose and insulin stimulate heparin-releasable lipoprotein lipase activity in mouse islets and INS-1 cells. A potential link between insulin resistance and beta-cell dysfunction. Journal of Biological Chemistry 276:12162-12168.
Dagon Y., Avraham Y. and Berry E.M. (2006) AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes. Molecular Cell Biology Research Communications 340:43-47.
Darlington G.J., Rose S.E. and MacDougald O.A. (1998) The role ig C/EBP gene in adipocyte differentiation. Journal of Biological Chemistry 273:30057-30060.
Day C.P. (2006) From fat to inflammation. Gastroenterology 130:207-210.
Day C.P. and James O.F. (1998) Steatohepatitis: a tale of two “hits’? Gastroenterol-ogy 114:842-845.
Deuchi K., Kanauchi O., Shizukuishi M. and Kobayashi E. (1994) Decreasing ef-fect of chitosan on the apparent fat digestibility by rats fed on a high-fat diet. Bio-science, Biotechnology, and Biochemistry 58:1613-1616.
D#westeur046#ez J.J. and Iglesias P. (2003) The role of the novel adipocyte-derived hormone ad-iponectin in human disease. European Journal of Endocrinology 148:293-300.
Dobbins R.L., Szczepaniak L.S., Zhang W., and McGarry J.D. (2003). Chemical sympathectomy alters regulation of body weight during prolonged ICV leptin infu-sion. American journal of physiology. Endocrinology and Metabolism 284:778-787.
Dodane V., Khan M.A. and Merwin J.R. (1999) Effect of chitosan on epithelial permeability and structure. International Journal of Pharmaceutics 182:21-32.
Dowman J.K., Tomlinson J.W. and Newsome P.N. (2010) Pathogenesis of non-alcoholic fatty liver disease. An International Journal of Medicine 103:71-83.
Drewnowski A. and Specter S.E. (2004) Poverty and obesity: the role of energy density and energy costs. American Journal of Clinical Nutrition 79:6-16.
Drucker D.J. (2006) The biology of incretin hormones. Cell Metabolism 3:153-165.
Duvnjak M., Lerotić I., Barsić N., Tomasić V., Virović J. L.and Velagić V. (2007) Pathogenesisand management issues for non-alcoholic fatty liver disease. World Journal of Gastroenterology 13:4539-4950.
Eberle D., Hegarty B., Bossard P., Ferre P. and Foufelle F. (2004) SREBP tran-scription factors: master regulators of lipid homeostasis. Biochimie 86:839-848.
Eissele R., Goke R., Willemer S., Harthus H.P., Vermeer H., Arnold R. and Goke B. (1992) Glucagon –like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. European Journal of Clinical Nutrition 22:283-291.
Elizabeth M.B. (2001) Nonalcoholic steatohepatitis: definition and pathology. Semi-nars in Liver Disease 2001:21:3-16.
Fabbrini E., Mohammed B.S., Magkos F., Korenblat K.M., Patterson B.W. and Klein S. (2008) Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134:424-431.
Faust I.M., Miller W.H., Sclafani A., Aravich P.F., Triscari J. and Sullivan A.C. (1984) Diet-dependent hyperplastic growth of adipose tissue in hypothalamic obese rats. American Journal of Physiology 247:1038-1046.
Feldstein A.E, Werneburg N.W., Canbay A., Guicciardi M.E., Bronk S.F. and Rydzewski R. (2004) Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40:185-194.
Fernande-Hernando C. and Moore K.J. (2011) MicroRNA modulation of choles-terol homeostasis. Journal of the American Heart Association 32:2378-2382.
Fisher R.M., Coppack S.W., Humphreys S.M., Gibbons G.F. and Frayn K.N. (1995) Human triacylglycerol-rich lipoprotein subfractions as substrates for lipo-protein lipase. Clinica Chimica Acta 236:7-17.
Florence A.T., Hillery A.M., Hussain N. and Jani P.U. (1995) Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. Journal of Controlled Release 36:39-46.
Folch J., Less M. and Sloane Stanley G.H. (1957) A simple method for the isolation and purification of total lipides from animal tissues. Journal of Biological Chemistry 226:497-509.
Fonseca-Alaniz M.H., Takada J., Alonso-Vale M.I. and Lima F.B. (2007) Adipose tissue as an endocrine organ: from theory to practice. Jornal de Pediatria 83:192-203.
Friedman A.D. and McKnight S.L. (1990) Identification of two polypeptide seg-ments of CCAAT/enhancer-binding protein required for transcriptional activation of the serum albumin gene. Genes &; Development 4: 1416-1426.
Fukada Y., Kimura K. and Ayaki Y. (1991) Effect of chitosan feeding on intestine bile acid metabolism in rats. Lipids 26:395-399.
Fungwe T.V., Cagen L.M., Wilcox H.G. and Hemimberg M. (1992) Regulation of hepatic secretion of very low density lipoprotein by dietary cholesterol. Journal of Lipid Research 33:179-191.
Gaidhu M.P., Anthony N.M., Patek P., Hawke T.J. and Ceddia R.B. (2010) Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adi-pocytes by high-fat diet: role of ATGL, HSL, and AMPK. American Journal of Physiology. Cell physiology 298:961-967.
Gallaher C.M., Munion J., Hesslink R.Jr., Wise J. and Gallaher D.D. (2000) Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. Journal of Nutrition 130:2753-2759.
Gallaher D.D., Gallaher C.M., Mahrt G.J., Carr T.P., Hollingshead C.H., Hess-link R.J. and Wise J.A. (2002) Glucomannan and chitosan fiber supplement de-creases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans. Journal of the American College of Nutrition 21:428-433.
Gao S., He L., Ding Y.L. and Liu G. (2010) Mechanisms underlying different re-sponses of plasma triglyceride to high-fat diets in hamsters and mice: Roles of he-patic MTP and triglyceride secretion. Biochemical and Biophysical Research Communications 398:619-626.
Garton A.J., Campbell D.G., Carling D., Hardie D.G., Colbran R.J. and Yeaman S.J. (1989) Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism. European Journal of Biochemistry 179:249-254.
Gavrilova O., Haluzik, M., Matsusue, K., Cutson J.J., Johnson L., Dietz K.R., Nicol C.J., Vinson C., Gonzalez F.J. and Reitman M.L. (2003) Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clear-ance, and regulation of body fat mass. Journal of Biological Chemistry 278:34268-34276.
Ge H., Cha J.Y., Gopal H., Harp C., Yu X., Repa J.J. and Li C. (2005) Differential regulation and properties of angiopoietin-like 3 and 4. Journal of Lipid Research 46:1484-1490.
Gibbons G.F. and Wiggins D. (1995) Intracellular triacylglycerol lipase: its role in the assembly of hepatic very-low-density lipoprotein (VLDL). Advances in Enzyme Regulation 35:179-198.
Gleeson A., Anderton K., Owens D., Bennett A., Collins P., Johnson A., White D. and Tomkin G.H. (1999) The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia 42:944-949.
Goldberg I.J. (1996) Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. Journal of Lipid Research 37:693-707.
Gordon D.A. and Jamil H. (2000) Progress towards understanding the role of mi-crosomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochimica et Biophysica Acta 1486:72-83.
Green A., Dobias S.B., Walters D.J. and Brasier A.R. (1994) Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase. Endocrinology 134:2581-2588.
Grunfeld C. and Feingold K.R. (1992) Tumor necrosis factor, interleukin, and in-terferon induced changes in lipid metabolism as part of host defense. Proceedings of the Society for Experimental Biology 200:224-227.
Hamilton R.L., Regen D.M., Gray M.E. and LeQuire V.S. (1967) Lipid transport in liver. I. Electron microscopic identification of very low density lipoproteins in perfused rat liver. Laboratory Investigation 16:305-319.
Hardie D.G. (2004) The AMP-activated protein kinase pathway-new players up-stream and downstream. Journal of Cell Sciences 117:5479-5487.
Hardie D.G., Scott J.W., Pan D.A., and Hudson E.R. (2003) Management of cellu-lar energy by the AMP-activated protein kinase. FFBS Letters 546:113-120.
Havel R.J., and Kane J.P. (1995) Introduction. Structure and metabolism of plasma lipoproteins. In The Metabolic and Molecular Basis of Inherited Disease. McGraw-Hill, New York 7:1841-1851.
Havinga R., Vonk R.J., Princen H.H.G., and Havekes L.M. (1996) Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver. Hepatology 24: 241–247.
Hayes M.R., Leichner T.M., Zhao S., Lee G.S., Chowansky A., Zimmer D., De Jonghe B.C., Kanoski S.E., Grill H.J. and Bence K.K. (2011) Intracellular sig-nals mediating the food intake suppressive effects of hindbrain gluca-gon-like-peptode-1 receptor activation. Cell Metabolism 13:320-330.
He Y., Chen H., Quon M.J. and Reitman M. (1995) The mouse obese gene: genomic organization, promotor activity, and activation by CCAAT/enhancerbinding protein α. Journal of Biological Chemistry 270:28887–28891.
Hertzel A.V. and Bernlohr D.A. (2000) The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends in Endocri-nology and Metabolism 11:175-180.
Hernandez-Gonzalez S.O., Gonzalez-Ortiz M., Martinez-Abundis E. and Ro bles-Cervantes J.A. (2010) Chitosan improves insulin sensitivity as determined by the euglycemic-hyperinsulinemic clamp technique in obese subjects. Nutrition Re-search 0:392-395.
Hoffler U., Hobbie K., Wilson R., Bai R., Rahman A., Malarkey D., Travlos G. and Ghanayem B.I. (2009) Diet induced obesity associated with hyperleptinemia, hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57B1/6J mice. Endo-crine 36:311-325.
Holm C. (2003) Molecular mechanisms regulating hormone-sensitive lipase and li-polysis. Biochemical Society Transactions 31:1120-1124.
Horton J.D., Goldstein J.L. and Brown M.S. (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. Journal of Clinical Investigation 109:1125-1131.
Horton J.D., Shimano H., Hamilton R.L., Brown M.S and Goldstein J.L. (1999) Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyper-lipidemia resulting from production of lipid-rich VLDL. Journal of Clinical Inves-tigation 103:1067-76.
Horton J.D., Shimomura I., Brown M.S., Hammer R.E., Goldstein J.L. and Shimano H. (1998) Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regu-latory element-binding protein-2. Journal of Clinical Investigation 101:2331-2339.
Hossain S., Rahman A., Kabir Y., Shams A. A., Afros F. and Hashimoto M. (2007) Effects of shrimp (Macrobracium Rosenbergii) - derived chitosan on plasma lipid profile and liver lipid peroxide levels in normo- and hypercholesterolaemic rats. Clinical and Experimental Pharmacology and Physiology 34:170-176.
Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L. and Spiegelman B.M. (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. Journal of Clinical Investigation 95:2409-2415.
Hotamisligil G.S., Johnson R.J., Distel R.J., Ellis R., Papaioannou V.E. and Spiegelman B.M. (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274:1377-1379.
Hsu L.W., Lee P.L., Chen C.T., Mi F.L., Juang J.H., Hwang S.M., Ho Y.C. and Sung H.W. (2012) Elucidating the signaling mechanism of an epithelial tight-junction opening induced by chitosan. Biomaterials 33:6254-6363.
Hsu R.Y. and Lardy H.A. (1969) Malic enzyme. In Methods in enzymology 13:230-235.
Hwang C.S., Mandrup S., MacDougald O.A., Geiman D.E. and Lane M.D. (1996) Transcriptional activation of the mouse obese (ob) gene by CCAAT/ enhancer binding protein α. Proceedings of the National Academy of Sciences 93:873-877.
Innerarity T.L., Bor#westeur042#n J., Yamanaka S. and Olofsson S.O. (1996) Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms. Journal of Biological Chemistry 271:2353-2356.
James W.P. (2008) The fundamental drivers of obesity epidemic. Obesity Reviews 9:6-13.
Janet D.S and Charles E.S. (2008) Overindulgence and metabolic syndrome: is FoxO1 a missing link? Journal of Clinical Investigation 118:2012-2015.
Jennings C.D., Boleyn K., Bridges S.R., Wood P.J. and Anderson J.W.A. (1988) Comparison of the lipid lowering and intestine morphological effect of cholestyra-mine, chitosan, and oat gum in rats. Society for Experimental Biology and Medicine (New York, N.Y.) 189:13-20.
Johnson T.O., Ermolieff J. and Jirousek M.R. (2002) Protein tyrosine phosphatase 1b inhibitors for diabetes. Nature review 9:696-709.
Jones A.L, Ruderman N.B. and Herrera M.G. (1996) An electron microscopic study of lipoprotein production and release by the isolated perfused rat liver. Pro-ceedings of the Society for Experimental Biology and Medicine 123:4-9.
Josue M., Jin W.W., Dodson M.V., Hausman G.J., Moore S.S. and Guan L.L. (2011) MicroRNA regulation in mammalian adipogenesis. Biology and Medicine 236:97-104.
Kaats G.R., Michalek J.E. and Preuss H.G. (2006) Evaluating efficacy of a chi-tosan product using a double-blinded, placebo-controlled protocol. Journal of the American College of Nutrition 25:389-394.
Kaestner K.H., Christy R.J. and Lane M.D. (1990) Mouse insulin-responsive glu-cose transporter gene: Characterization of the gene and trans-activation by the CCAAT/enhancer binding protein. Proceedings of the National Academy of Sciences 87: 251-255.
Kahn B.B, Alquier T., Carling D. and Hardie D.G. (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabo-lism. Cell metabolism 1:15-25.
Kim I., Kim H.G., Kim H., Kim H.H., Park S.K., Uhm C.S., Lee Z.H. and Koh G.Y. (2000) Hepatic expression, synthesis and secretion of a novel fibrinogen/ an-giopoietin-related protein that prevents endothelial-cell apoptosis. Biochemical Journal 346:603-610.
Kim I., Moon S.O., Koh K.N., Kim H., Uhm C.S., Kwak H.J., Kim N.G. and Koh, G. Y. (1999) Molecular cloning, expression, and characterization of angiopoiet-in-related protein. Journal of Biological Chemistry 274:26523-26528.
Kim J.B. and Spiegelman B.M. (1996) ADD1/SREBP1 promotes adipocyte differ-entiation and gene expression linked to fatty acid metabolism. Genes &; Develop-ment 10:1096-1107.
Kim J.B., Sarraf P., Wright M., Yao K.M., Mueller E., Solanes G., Lowell B.B. and Spiegelman B.M. (1998) Nutritional and insulin regulation of fatty acid syn-thetase and leptin gene expression through ADD1/SREBP1. Journal of Clinical Investigation 101:1-9.
Kim J.B., Wright H.M., Wright M. and Spiegelman B.M. (1998) ADD1/SREBP1 activates PPARγ through the production of endogenous ligand. Proceedings of the National Academy of Sciences 95:4333-4337.
Klementina F.T. and Damjana R. (2011) Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation. Journal of Lipids 2011:1-14.
Knorr D. (1984) Use of chitinous polymers in food: A challenge for food research and development. Food Technology 38:85-97.
Koishi R., Ando Y., Ono M., Shimamura M., Yasuma H., Fujiwara T., Horikoshi H. and Furukawa H. (2002) Angptl3 regulates lipid metabolism in mice. Nature Genetics 30:151-157.
Kong C.S., Kin J.A., Bak S.S., Byun H.G. and Kim S.E. (2009) Anti-obesity effect of carboxymethyl chitin by AMPK and aquaporin-7 pathways in 3T3-L1 adipocytes. Journal of Nutritional Biochemistry 22:276-281.
Krȕner G. and Westernhage H.V. (1999) Sources of measurement error in assays of EROD activity of fish for biological effects monitoring. Helgoland Marine Re-search 53:250-256.
Kumar S.G., Rahman M.A., Lee S.H., Hwang H.S., Kim H.A. and Yun J.W. (2009) Plasma proteome analysis for anti-obesity and anti-diabetic potentials of chitosan oligosaccharides in ob/ob mice. Preoteomics 9:2149-2162.
Kumar, Ravi and Majeti N.V. (2000). A review of chitin and chitosan applications. Reactive &; Functional Polymers 46:1-27.
Kurita K. (2006) Chitin and chitosan: Functional biopolymers from marine crusta-ceans. Marine Biotechnology 8:203-226.
Kusunoki M., Hara T., Tsutsumi K., Nakamura T., Miyata T., Sakamoto S., Og-awa H. and Nakaya Y. (2000) The lipoprotein lipase activator, NO-1886, sup-presses fat accumulation and insulin resistance in rats fed a high-fat diet. Diabeto-logia 43:875-880.
Large V., Reynisdottir S., Langin D., Fredby K., Klannemark M., Holm C. and Arner P. (1999) Decreased expression and function of adipocyte hor-mone-sensitive lipase in subcutaneous fat cells of obese subjects. Journal of Li-pid Research 40:2059-2065.
Lau D.C., Douketis J.D., Morrison K.M., Hramiak I.M., Sharma A.M. and Ur E. (2007) 2006 Canadian clinical practice guidelines on the management and preven-tion of obesity in adults and children summary. Canadian Medical Association Journal 176:11-13.
Laurent C., Patrice T., Fabienne N., Stephanie Z., Alain M., Eric B. and Chap-man M.J. (2002) LDL particle subclasses in hypercholesterolemia: Molecular de-terminants of reduced lipid hydroperoxide stability. Journal of Lipid Research 43:453-462.
Lazar M.A. (2005) PPARγ, 10 years later. Biochimie 87:9-13.
Le Jan S., Amy C., Cazes A., Monnot C., Lamande N., , Favier J., Philippe J., Sibonym M., Gasem J.M., Corvol P. and Germain S. (2003) Angiopopietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. American Journal of Pathology 162:1521-1528.
Lefevre M.E., Vanderhoff J.W., Laussue J.A. and Joel D.D. (1978) Accumulation of 2-mm latex particles in mouse Peyer’s patches during chronic latex feeding. Experientia 34:120-122.
Lehoux J.G. and Grondin F. (1993) Some effect of chitosan on live function in the rat. Endocrinogy 132:1078-1084.
Lehrke M. andLazar M.A. (2005) The many faces of PPARγ. Cell 123:993-999.
Lessard S.J., Chen Z.P., Watt M.J., Hashem M., Reid J.J., Febbraio M.A., Kemp B.E. and Hawley J.A. (2006) Chronic rosiglitazone treatment restores AMPKal-pha2 activity in insulin-resistant rat skeletal muscle. American Journal of Physiology. Endocrinology and metabolism 290:251-257.
Lewis G.F., Uffelman K., Naples M., Szeto L., Haidari M. and Adeli K. (2005) Intestinal lipoprotein overproduction, a newly recognized component of insulin re-sistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fruc-tose-fed Syrian Golden hamster. Endocrinology 146:247-255.
Li Y., Xu S.Q., Mihaylova M.M., Zheng B., Hou X.Y., Jiang B.B., Park O., Luo Z., Lefai E., Shyy J.Y.J., Gao B., Wierzbicki M,. Verbeuren T.J., Shaw R.J., Cohen R.A. and Zang M. (2011) AMPK phosphorylates and inhibits SREBP ac-tivity to attenuate hepatic steatosis and atherosclerosis in diet induced insulin re-sistant mice. Cell Metabolism 13:376-388.
Lim B.O., Yamada K., Nonaka M., Kuramoto Y., Hung P. and Sugano M. (1997) Dietary fibers modulate indices of intestinal immue fuction in rats. Journal of Nu-trition 127:663-667.
Lin E.C.K., Fernandez M.L. and Mcnamara D.J. (1992) Dietary fat type and cho-lesterol quantity interact to affect cholesterol metabolism in guinea pig. Journal of Nutrition 122:2019-2029.
Lin F.T. and Lane M.D. (1992) Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during dif-ferentiation of 3T3-L1 preadipocytes. Genes &; Development 4:533-544.
Liu J., Zhang J. and Xia W. (2008) Hypocholesterolaemic effects of different chi-tosan samples in vitro and in vivo. Food Chemistry 107:419-425.
Liu L. and Ouyang D. (2009) Function and clinical significance of microsomal tri-glyceride transfer protein. International Journal of Pathology and Clinical Medicine 29:152-154.
Liu Y., Wan Q., Guan Q., Gao L. and Zhao J. (2006) High-fat diet feeding impairs both the expression and activity of AMPKα in rats skeletal muscle. Biochemical and Biophysical Research Communications 339:701-707.
Lu S.N., Wang L.Y., Chang W.Y., Chen C.J., Su W.P., Chen S.C., Chuang W.L. and Hsieh M.Y. (1990) Abdominal sonographic screening in a single community. Kaohsiung Journal of Medical Sciences 6:643-646.
Lu Y.F. and Chiang C.F. (2001) Effect of dietary cholesterol and fat levels on lipid peroxidation and the activities of antioxidant enzymes in rats. International Journal for Vitamin and Nutrition Research 71:339-346.
Maezaki Y., Keisuke T., Nakagawa Y., Kawai Y., Akimoto M., Tsugita T., Takekawa W., Terada A., Hara H. and Mitsuoka T. (1993) Hypocholesterolemic effect of chitosan in adult males. Bioscience, Biotechnology, and Biochemistry 57:1439-1444.
Mahley R. W. and Huang Y. (1999). Apolipoprotein E: from atherosclerosis to Alz-heimer’s disease and beyond. Current Opinion in Lipidology 10: 207–217.
Martin T.L, Alquier T., Asakura K., Furukawa N., Preitner F. and Kahn B.B. (2006) Diet-induced obesity alters AMP kinase activity in hypothalamus and skele-tal muscle. Journal of Biological Chemistry 281:18933-18941.
Mason M.M., He Y., Chen H., Quon M.J. and Reitman M. (1998) Regulation of leptin promotor function by Sp1, C/EBP, and a novel factor. Endocrinology 139:1013-1022.
Mathiowitz E., Jacob J.S., Jong Y.S., Carino G.P., Chickering D.E., Chaturvedi P., Santos C.A., Vijayaraghavan K., Montgomery S., Bassett M. and Morrell C. (1997) Biologically erodible microspheres as potential oral drug delivery system. Nature 386:410-414.
Mathur N.K. and Narang C.K. (1990) Chitin and chitosan, versatile marine animal polysaccharides. Journal of Chemical Education 67:938-942.
Maugeais C., Tietge U.J.E., Tsukamoto K., Glick J.M. and Rader D.J. (2000) Hepatic apolipoprotein E expression promotes very low density lipopro-tein-apolipoprotein B production in vivo in mice. Journal of Lipid Research 41:1673-1679.
Michael W.K. (2013) AMPK: Master metabolic regulator. Retrieves May 15, 2014 from http://themedicalbiochemistrypage.org/ampk.php
Mihaylova M.M. and Shaw R.J. (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nature Cell Biology 13:1016-1023.
Minokoshi Y., Kim Y.B., Peroni O.D., Fryer L.G., Mullar C., Carling D., and Kahn B.B. (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339-343.
Miriam H.F.A., Julie T., Maria I.C.A.V. and Fabio B.L. (2007) Adipose tissue as an endocrine organ: from theory to practice, Jornal de Pediatria 83: 192-203.
Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S. and Marks J.S. (2003) Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001. Journal of the American Medical Association 289:76-79.
Moon M.S., Lee M.S., Kim C.T. and Kim Y. (2007) Dietary chitosan enhances he patic CYP7A1 activity and reduces plasma and liver cholesterol concentrations in diet-induced hypercholesterolemia in rats. Nutrition Research and Practice 1:175-179.
Muzzarelli R.A.A. and Rocchetti (1985) Determination of the degree of acetylation of chitosan by first derivative ultraviolet spectrophotometry. Carbohydrate Poly-mers 5:461-472.
Nagayma F., Ohshima H. and Umezawa K. (1972) Distribution of glu-cose-6-phosphate metabolyzing enzymes in fish. Nippon Suisan Gakkaishi 38:589-593.
Nakano M. and Inui A. (2014) Metformin and incretin-based therapies up-regulate central and peripheral Adenosine monophosphate-activated protein affecting appe-tite and metabolism. Indian Journal of Endocrinology and Metabolism 16:529-531.
Nepokroedd C.M.M.R., Lakshmanan and Porter W. (1975) Fatty acid synthase from rat liver. Methods in Enzymology 35:37-44.
Nestle M. and Jacobson M.F. (2000) Halting the obesity epidemic: a public health policy approach. Public Health Reports 115:12-24.
Neuschwander-Tetri B.A. and Caldwell S.H. (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37:1202-1219.
Nogaska A., Sucajtys-Szulc E. and Swierczynski J. (2005) Leptin decreases lipo-genic enzyme gene expression through modification of SREBP-1c gene expression in white adipose tissue of aging rats. Metabolism 54:1041-1047.
Numa S., Ringelmann E. and Lynen F. (1965) On inhibition of ace-tyl-CoA-carboxylase by fatty acid-coenzyme A compounds. Biochemische Zeitschrift 343:243-257.
Oike Y., Akao M., Kubota Y. and Suda T. (2005) Angiopoietin-like proteins: Poten-tial new targets for metabolic syndrome therapy. Trends in Molecular Medicine 11:474-479.
Oike Y., Ito Y., Maekawa H., Morisda T., Kubota Y., Akao M., Urano T., Yasunaga K. and Suda T. (2004) Angiopoietin-related growth factor (AGE) pro-motes angiogenesis. Blood 103:3760-3766.
One M., Shimizugawa T., Shimamura M., Yoshida K., Noji-Sakikawa C., Ando Y., Koisshi R. and Furukawa H. (2003) Protein region important for regulation of li-pid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and ac-tivated in vivo. Journal of Biological Chemistry 278:41804-41809.
Park E.A, Roesler W.J., Liu J., Klemm D.J., Gurney A.L., Thatcher J.D., Shu-man J.D., Friedman A. and Hanson R.W. (1990) The role of the CCAAT/enhancer-binding protein in the transcriptional regulation of the gene for phosphoenolpyruvate carboxykinase (GTP). Molecular and Cellular Biology 10: 6264-6272.
Peter A.E., Donna L., John K., Iahaiahu S. and Alan M.F. (1979) Properties of pu-rified rat hepatic 3-hydroxy-3-methylglutaryl coenzyme a reductase and regulation of enzyme activity. Journal of Biological Chemistry 255:3715-3725.
Phillips C., Bennett A., Anderton K., Owens D., Collins P., White D. and Tomkin GH. (2002 A) Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes. Metabolism 51:847-852.
Phillips C., Owens D., Collins P. and Tomkin G.H. (2002 B) Microsomal triglycer-ide transfer protein: does insulin resistance play a role in the regulation of chylomi-cron assembly? Atherosclerosis 160:355-360.
Pittler M.H., Abbot N.C., Harkness E.F. and Ernst E. (1999) Randomized, dou-ble-blind trial of chitosan for body weight reduction. European Journal of Clinical Nutrition 53:379-381.
Ponchel G. and Irache J. (1998) Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Advanced Drug Delivery Reviews 34:191-219.
Porstmann T., Santos C.R., Griffiths B., Cully M., Wu M., Leevers S., Griffiths J.R., Chung Y.L. and Schulze A. (2008) SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metabolism 8:224-236.
Prashanth K.V.H. and Tharanathan R.N. (2007) Chitin/chitosan: modifications and their unlimited application potentialdan overview. Trends in Food Science &; Tech-nology 18:117-131.
Quintao E.R.C and Sperotto G. (1987) The role of dietary cholesterol in the regula-tion of human body cholesterol metabolism. Advances in Lipid Research 22:173-188.
Rinaudo M. (2006) Chitin and chitosan: Properties and application. Progress in Polymer Science 31:603-632.
Roberts C.K., Barnard R.J., Liang K.H. and Vaziri N.D. (2002) Effect of diet on adipose tissue and sketetal muscle VLDL receptor and LPL: implications of obesity and hyperlipidemia. Atherosclecosis161:133-141.
Romao J.M., Jin W.W., Dodson M.V., Hausman G.J., Moore S.S. and Guan L.L. (2011) MicroRNA regulation in mammalian adipogenesis. Biology and Medicine 236:97-1004.
Rondinone C.M. (2006) Adipocyte-Derived Hormones, Cytokines, and Mediators. Endocrinology 29:81-90.
Ruderman N. and Prentki M. (2004) AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nature reviews. Drug discovery 3:340-351.
Rutter G.A, Silva, D.X.G., and Leclerc, I. (2003) Roles of 5’-AMP-activated pro-tein kinase (AMPK) in mammalian glucose homoeostasis. Biochemical Journal 375:1-16.
Sanders E. and Ashworth C.T. (1961) A study of particulate intestinal absorption and hepatocellular uptake. Experimental Cell Research 22:137-45.
Sanderson I.R. and Naik S. (2000) Dietary regulation of intestinal gene expression. Annual Review of Nutrition 20:311-338.
Sell H., Berger J.P., Samson P., Castriota G., Lalonde J., Deshaies Y. and Richard D. (2004) Peroxisome proliferator-activated receptor gamma agonism increases the capacity for sympathetically mediated thermogenesis in lean and ob/ob mice. En-docrinology 145:3925-3934.
Senevirathne M., Jeon Y.J., Kim Y.T., Park P.J., Jung W.K., Ahn C.B. and Je J.A. (2012) Prevention of oxidative stress in Chang liver cells by gallic ac-id-grafted-chitosans. Carbohydrate Polymers 87:876-880.
Seo J.B., Moon H.M., Noh M.J., Lee Y.S., Jeong H.W., Yoo E.J., Kim W.S., Park J., Youn B.S., Kim J.W., Park J., Youn B.S., Kim J.W., Park S.D. and Kim J.B. (2004) Adipocyte determination and differentiation-dependent factor 1/sterol regulatory element binding protein 1c regulates mouse adiponectin expression. Journal of Biological Chemistry 279:22108-22117.
Sessions V.A. and Salter A.M. (1994) The effects of different dietary fats and cho-lesterol on serum lipoprotein concentrations in hamsters. Biochimica et Biophysica Acta 1211:207-214.
Sethi J.K. and Hotamisligil G.S. (1999) The role of TNF alpha in adipocyte metabo-lism. Seminars in Cell &; Developmental Biology 10:19-29.
Shimamura M., Matsuda M., Kobayashi S., Ando Y., Ono M., Koishi R., Fu-rukawa H., Makishima M. and Shimomura I. (2003) Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochemical and Bio-physical Research Communication 301:604-609.
Shimano H., Horton J.D., Shimomura I., Hammer R.E., Brown M.S. and Gold-stein J.L. (1997) Isoform 1c of sterol regulatory element binding protein is less ac-tive than isoform 1a in livers of transgenic mice and in cultured cells. Journal of Clinical Investigation 99:846-854.
Shimomnura I., Shimano H., Horton J.D., Goldstein J.L. and Brown M.S. (1997) Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. Journal of Clinical Investigation 99:838-845.
Sonaje K., Lin K.J., Wey S.P., Lin C.K., Yeh T.H., Nguyen N.H., Hsua C.W., Yen T.C., Juang J.H. and Sung H.W. (2010). Biodistribution, pharmacodynamics and pharmacokinetics of insulin anaglogues in a rat model: Oral delivery using pH-Responsive nanoparticle vs. subcutaneous injection. Biomaterials 31:6849-6858.
Spigeliman B.M. and Flier J.S (2001) Obesity and the regulation of energy balance. Cell 104:531-543.
Stefan N., Kantartzis K. and H#westeur037#ring H.U. (2008) Causes and metabolic conse-quences of fatty liver. Endocrine Reviews 29:939-960.
Stejskal D. and Karpisek M. (2006) Adypocite fatty acid binding protein in Cauca-sian population: a new marker of metabolic syndrome? European Journal of Clinical Investigation 36:621-625.
Stryer L. (1998) Biochemistry, 3rd edn. Academic press, U.S.
Su C.L., Sztalrdy C., Contreras J.s., Holm C., Kimmel A.R. and Londos C. (2003) Mutational analysis of the hormone-sensitive lipase translocation reaction in adi-pocytes. Journal of Biological Chemistry 278:43615-43619.
Sugano M., Fujikawa Y., Hiratsuji K., Nakashima N. and Hasegawa Y. (1980) A novel use of chitosan as a hypocholesterolemic agent in rats. American Journal of Clinical Nutrition 33:787-793.
Sugano M., Watanabe S., Kishi A., Izume M. and Ohtakara A. (1988) Hypocho-lesterolemic action of chitosan with different viscosity in rats. Lipids 9:919-927.
Sukonina V., Lookene A., Olivecrona T. and Olivecrona G. (2006) Angiopoiet-in-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proceedings of the National Academy of Sciences 103:17450-17455.
Sullivan J.E., Brocklehurst K.J., Marley A.E., Carey F., Carling D. and Beri R.K. (1994) Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. Index of Biochemical Reviews 353:33-36.
Sumiyoshi M. and Kimura Y. (2006) Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-term in mice. Journal of Pharmacy and Pharmacology 58:201-207.
Susan G. and Jason K.K. (2011) New insights into insulin resistance in the diabetic heart. Trends in Endocrinology &; Metabolism 22:394-403.
Tacer K.F. and Rozman D. (2011) Nonalcoholic fatty liver disease: focus on lipo-protein in lipid deregulation. Journal of Lipid 2011:1-14.
Tamura S. and Shimomura I. (2005) Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. Journal of Clinical Investigation 115:1139-1142.
Tietge U.J., Bakillah A., Maugeais C., Tsukamoto K., Hussain M. and Rader D.J. (1999) Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. Journal of Lipid Research 40:2134-2139.
Tisdale M.J. (2005) Molecular pathways leading to cancer cachexia. Physiology 20:340-348.
Trayhurn P. and Beattie J.H. (2001) Physiological role of adipose tissue: white ad-ipose tissue as an endocrine and secretory organ. Proceedings of the Nutrition Soci-ety 60:329-339.
Tso A., Xu A.W., Sham P., Wat N.M., Wang Y., Fong H.Y., Cheung M.Y., Janus E.D. and Lam S.L. (2007) Serum adipocyte fatty acid-binding protein as a new biomarker predicting the development of type 2 diabetes. Diabetes Care 30:2667-2672.
Tsukamoto K., Maugeais C., Glick J.M. and Rader D.J. (2000) Markedly in-creased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice. Journal of Lipid Research 41: 253-259.
Valet P., Tavernier G., Laurell C.I., Blache J.S.S. and Langin D. (2002) Under-standing adipose tissue development from transgenic animal models. Journal of Li-pid Research 43:835-860.
Van de Velde K. and Kiekens P. (2004) Structure analysis and degree of substitution of chitin, chitosan and debutyrylchitin by FT-IR spectroscopy and solid state C-13 NMR. Carbohydrate Polymers 58:409-416.
Van der Lubben I.M., Konings F.A., Borchard G., Verhoef J.C. and Junginger H.E. (2001A) In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohisto-chemistry. Journal of Drug Targeting 9:39-47.
Van der Lubben I.M., Verhoef J.C., Van Aelst A.C., Borchard G. and Junginger H.E. (2001B) Chitosan microparticles for oral vaccination: preparation, character-ization and preliminary in vivo uptake studies in murine Peyer's patches. Bio-materials 22:87-694.
Wang D., Wei Y. and Pagliassotti M.J. (2006) Saturated fatty acids promote endo-plasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 147:943-951.
Wanless I.R. and Lentz J.S. (1990) Fatty liver hepatitis (steatohepatitis) and obesity: autopsy study with analysis of risk factors. Hepatology 12:1106-1110.
Ward P.D., Tippin T.K. and Thakker D.R. (2000) Enhancing paracellular permea-bility by modulating epithelial tight junctions. Pharmaceutical Science &; Tech-nology Today 3:346-358.
Watson K.E., Horowitz B.N. and Matson G. (2003) Lipid abnormalities in insulin resistant states. Reviews in Cardiovascular Medicine 4:228-236.
White D.A., Bennett A.J., Billett M.A. and Salter A.M. (1998) The assembly of triacylglycerol-rich lipoproteins: an essential role for the microsomal triacylglycerol transfer protein. British Journal of Nutrition 80:219-229.
Wickelgren I. (1988) Obesity how big problem. Scinence 280:1364-1367.
Wilkes J.J., Nguyen M.T., Bandyopadhyay G.K., Nelson E. and Olefsky J.M. (2005) Topiramate treatment causes skeletal muscle insulin sensitization and in-creased Acrp30 secretion in high-fat-fed male Wistar rats. American Journal of Physiology. Endocrinology and metabolism 289:1015-1022.
World Health Organization (2004) BMI classification. Global database on body mass index. Retrieves May 15, 2004 from http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.
World Health Organization (2005) The World Health Organization warns of the rising threat of heart disease and stroke as overweight and obesity rapidly increase. Retrieves May 11, 2014 from http://www.who.int/mediacentre/news/releases/2005/pr44/en/.
Xia W., Liu P., Zhang J. and Chen J. (2011) Biological activities of chitosan and chitooligosaccharides. Food Hydrocolloids 25:170-179.
Xu A., Tso A.W., Cheung B.M., Wang Y., Wat N.M., Fong H.Y., Yeung C.Y., Ja-nus E.D., Sham M.D. and Lam S.L. (2007) Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 115:1537-1543.
Xu A., Wang Y., Yu S.J., Stejskal D. and Tam S. (2006) Adipocyte fatty acid bind-ing protein is a plasma biomarker associated with obesity and Metabolic Syndrome. Clinical Chemistry 52:405-413.
Xu G., Huang X., Qiu L., Wu J. and Hu Y. (2007) Mechanism study of chitosan on lipid metabolism in hyperlipidemic rats. Asia Pacific Journal of Clinical Nutrition 16:313-317.
Yang P.M., Huang G.T. and Sheu J.C. (1986) Mass screening of hepatobiliary dis-eases by real-time ultrasonography. Journal of the Formosan Medical Association 85:1144-1150.
Yang Z.H., Miyahara H., Takeo J. and Katayama M. (2012) Diet high in fat and sucrose induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation in mice. Diabetology and Metabolic Syndrome 4:32-42.
Yao H.T., Huang S.Y. and Chiang M.T. (2008) A comparative study on hypoglyce-mic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats. Food and Chemical Toxicology 46:1525-1534.
Yao H.T., Lii C.K., Chou R.H., Lin J.H., Yang H.T. and Chiang M.T. (2010) Ef-fect of chitosan on hepatic drug metabolizing enzymes and oxidative stress in rats fed low- and high-fat diets. Journal of Agricultural and Food Chemistry 58:5187-5193.
Yin W., Mu J. and Birnbaum M.J. (2003) Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis in 3T3-L1 adipocytes. Journal of Biological Chemistry 278:43074-43080.
You M., Matsumoto M., Pacold C.M., Cho W.K., Crabb D.W. (2004) The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 127:1798-1808.
Young S. (1990) Recent progress in understanding apolipoprotein B. Circulation 82: 1574–1594.
Zammit V.A. (1996) Role of insulin in hepatic fatty acid partitioning: emerging con-cepts. Biochemical Journal 314:1-14.
Zeng L.T., Qin C.Q., Wang W., Chi W.L. and Li W. (2008) Absorption and distri-bution of chitosan in mice after oral administration. Carbohydrate Polymers 71:435-440.
Zhang H.H., Halbleib M., Ahmad F., Manganiello V.C. and Greenberg A.S. (2002) Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51:2929-2935.
Zhang Y., Proenca R., Maffei M., Barone M., Leopold L. and Friedman J.M. (1994) Positional cloning of the mouse obese gene and its human homologue. Na-ture 372:425-32.
何思頻,2011。幾丁聚醣對於高蔗糖飲食誘發耐糖不良大鼠餐後脂質代謝之影響。國立臺灣海洋大學食品科學系碩士論文。呂佳珊,2012。幾丁聚醣對自發性高血壓大白鼠血壓及脂質代謝之影響。國立臺灣海洋大學食品科學系碩士論文。李冠儀,2012。次微米幾丁聚醣對高脂飲食大白鼠醣類及脂質代謝之影響。國立臺灣海洋大學食品科學系碩士論文。胡錦珍,張家驪,程沁園,高娟,夏文水,2009。殼聚醣在小鼠體內的組織分布 與排泄。食品與生物技術學報28:611-615。
范建高,曾文德,2005。脂肪性肝病。人民衛生出版社。中國。北京。
許弘昇,2004。不同膽固醇添加量對倉鼠脂質代謝之影響。國立臺灣海洋大學食品科學系碩士論文。陳韻如,2012。長期攝食幾丁聚及維生素C對Streptozotocin-Nicotinamide誘發之第2型糖尿病大白鼠在餵食高膽固醇飲食下其醣類及脂質代謝之影響。國立臺灣海洋大學食品科學系碩士論文。曾憲鵬,2009。高與低分子量幾丁聚醣對streptozotocin/nicotinamide誘發之第2型糖尿病大白鼠糖代謝和脂質代謝之影響。國立臺灣海洋大學食品科學系碩士論文。楊重熙,2008。奈米科技於活體智慧型靶向傳遞系統之設計與臨床醫療之應用研究,國家衛生研究院電子報,第267期。
蔡鈁瀅,2011。幾丁聚醣對高果糖誘發代謝症候群大白鼠之影響。國立臺灣海洋大學食品科學系碩士論文。衛生褔利部,2002。成人健康體位標準。臺北。臺灣。
衛生褔利部,2013A。民國101年國人十大死因統計。臺北。臺灣。
衛生褔利部,2013B。臺灣地區國民營養健康狀況變遷調查。臺北。臺灣。
謝侑霖,2010。幾丁聚醣影響Streptozotcin-nicotinamide 誘發之耐糖不良大白鼠脂肪組織之研究。國立臺灣海洋大學食品科學系碩士論文。